CS
Chandrappa Seetharamaiah
About Chandrappa Seetharamaiah
Data last updated:
Chandrappa Seetharamaiah is a Designated Partner at Pronomz Ventures Llp (since 2021), Designated Partner at Agnus Capital Llp (since 2022) and Director at Steriscience Specialties Private Limited (since 2021), and holds 12 more current directorships. The companies operate in Business Outsourcing, Pharma and Healthcare. The 6 current companies with reported revenue have a combined latest revenue of ₹52.63 Cr; the largest is Pronomz Ventures Llp at ₹21.31 Cr (FY 2020). Earlier, Chandrappa Seetharamaiah was a Designated Partner at Qualichem Remedies Llp (2021–2025) and Designated Partner at Six Rays Pharma Solutions Llp (2021–2022) and 21 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pronomz Ventures Llp AAA-3757 | Designated Partner | 11 Jan 2021 | 2011 | ₹21.31 Cr (FY 2020) | Active |
 Agnus Capital Llp AAA-1670 | Designated Partner | 05 Mar 2022 | 2010 | ₹18.21 Cr (FY 2023) | Active |
| Steriscience Specialties Private Limited U24304MH2020PTC424881 | Director | 02 Jun 2021 | 2020 | ₹9.53 Cr (FY 2025) | Active |
| Hydra Active Pharma Sciences Private Limited U74999KA2016PTC197435 | Director | 31 Dec 2020 | 2016 | ₹1.97 Cr (FY 2023) | Active |
 Skanray Healthcare Global Private Limited U85100KA2013PTC068496 | Director | 24 Dec 2022 | 2013 | ₹1.47 Cr (FY 2025) | Active |
| Chayadeep Ventures Llp AAA-1669 | Designated Partner | 05 Mar 2022 | 2010 | ₹13.1 Lakh (FY 2023) | Active |
| Devicam Capital Llp AAB-9882 | Designated Partner | 11 Jan 2021 | 2014 | Active | |
| Karuna Business Solutions Llp AAD-0057 | Designated Partner | 14 Oct 2024 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Qualichem Remedies Llp AAA-1774 | Designated Partner | 29 Jan 2021 | 2010 | Active | |
| Six Rays Pharma Solutions Llp AAS-6730 | Designated Partner | 11 Jan 2021 | 2020 | Active | |
 Naari Pharma Private Limited U74899KA1978PTC142872 | Nominee Director | 24 Mar 2018 | 1978 | ₹136 Cr (FY 2025) | Active |
| Instapill Private Limited U24230KA2007PTC042337 | Director | 04 May 2023 | 2007 | ₹101 Cr (FY 2025) | Active |
| Tenshi Pharmaceuticals Private Limited U70200KA2016PTC200180 | Director | 31 Jul 2018 | 2016 | ₹1,071 Cr (FY 2024) | Active |
 Triphase Pharmaceuticals Private Limited U73100KA2006PTC039605 | Director | 31 Dec 2020 | 2006 | ₹6 Lakh (FY 2022) | Active |
| Chayadeep Properties Private Limited U45203KA2003PTC094179 | Additional Director | 14 Jan 2016 | 2003 | ₹16.74 Cr (FY 2025) | Active |
| Agnus Assisted Living Private Limited U85300KA2013PTC069093 | Director | 13 Nov 2017 | 2013 | ₹40,152 (FY 2025) | Active |
| Farmgenus Private Limited U01100KA2019PTC125793 | Director | 31 Dec 2020 | 2019 | Strike Off | |
| Tenshi Ksm Private Limited U24299KA2019PTC121725 | Director | 31 Dec 2020 | 2019 | ₹17.6 Lakh (FY 2021) | Dissolved Under Section 59(8) |
| Stellence Life Sciences Private Limited U24299KA2019PTC126688 | Additional Director | 11 Jan 2021 | 2019 | Strike Off | |
| Pronomz Holdings Private Limited U65993KA2020PTC138132 | Director | 20 Jan 2021 | 2020 | Strike Off | |
| Tenshi Life Sciences Private Limited U74110TN2016PTC126537 | Whole-Time Director | 26 Feb 2021 | 2016 | ₹160 Cr (FY 2021) | Amalgamated |
| Tenshi Healthcare Private Limited U74999TN2018PTC125505 | Director | 31 Dec 2020 | 2018 | Strike Off | |
| Naturalt Biomaterials Private Limited U21001KA2023PTC172145 | Director | 10 Apr 2023 | 2023 | Strike Off | |
| Seekers Ally Llp AAL-5838 | Designated Partner | 29 Jan 2021 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chandrappa Seetharamaiah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramaprasad Jyothinagaravyasha Sriraman | 00173696 | Pronomz Ventures Llp , Agnus Capital Llp and 12 more | Designated Partner |
| Arun Kumar Pillai | 00084845 | Agnus Capital Llp , Chayadeep Ventures Llp | Designated Partner |
| K R Ravishankar | 00084908 | Agnus Capital Llp , Chayadeep Ventures Llp | Designated Partner |
| Chhitiz Saraogi | 10626776 | Steriscience Specialties Private Limited | Director |
| Kavita Swame | 08099527 | Skanray Healthcare Global Private Limited | Whole-Time Director |
| Lakshmi Dayanand Kamath | Skanray Healthcare Global Private Limited | Cfo | |
| Sowmya Kiran | Skanray Healthcare Global Private Limited | Company Secretary | |
| Akila Chandrashekar Raju | 07590312 | Devicam Capital Llp | Partner |
| Shridhara Kela | 02592314 | Devicam Capital Llp | Partner |
| Vishwaprasad Alva | 01240253 | Skanray Healthcare Partners Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrappa Seetharamaiah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrappa Seetharamaiah
Chandrappa Seetharamaiah currently holds 15 directorships: Pronomz Ventures Llp (Designated Partner, since 11 Jan 2021, revenue ₹21.31 Cr (FY 2020)); Agnus Capital Llp (Designated Partner, since 05 Mar 2022, revenue ₹18.21 Cr (FY 2023)); Steriscience Specialties Private Limited (Director, since 02 Jun 2021, revenue ₹9.53 Cr (FY 2025)); Hydra Active Pharma Sciences Private Limited (Director, since 31 Dec 2020, revenue ₹1.97 Cr (FY 2023)); Skanray Healthcare Global Private Limited (Director, since 24 Dec 2022, revenue ₹1.47 Cr (FY 2025)); and 10 more.
Chandrappa Seetharamaiah was first appointed on 14 Jan 2016 as Additional Director at Chayadeep Properties Private Limited. The most recent appointment on record is 14 Oct 2024 at Karuna Business Solutions Llp.
The 6 current companies of Chandrappa Seetharamaiah that report revenue have a combined latest revenue of ₹52.63 Cr: Pronomz Ventures Llp ₹21.31 Cr (FY 2020); Agnus Capital Llp ₹18.21 Cr (FY 2023); Steriscience Specialties Private Limited ₹9.53 Cr (FY 2025); Hydra Active Pharma Sciences Private Limited ₹1.97 Cr (FY 2023); Skanray Healthcare Global Private Limited ₹1.47 Cr (FY 2025); and 1 more.
Chandrappa Seetharamaiah held 23 earlier board appointments: Qualichem Remedies Llp (Designated Partner, 29 Jan 2021 to 06 Jun 2025); Six Rays Pharma Solutions Llp (Designated Partner, 11 Jan 2021 to 05 Mar 2022); Naari Pharma Private Limited (Nominee Director, 24 Mar 2018 to 24 Jul 2025); Instapill Private Limited (Director, 04 May 2023 to 11 Feb 2025); Tenshi Pharmaceuticals Private Limited (Director, 31 Jul 2018 to 04 Jun 2024); and 18 more.
The current boards of Chandrappa Seetharamaiah's companies include Ramaprasad Jyothinagaravyasha Sriraman (Pronomz Ventures Llp), Arun Kumar Pillai (Agnus Capital Llp), K R Ravishankar (Agnus Capital Llp), Chhitiz Saraogi (Steriscience Specialties Private Limited), Kavita Swame (Skanray Healthcare Global Private Limited), Lakshmi Dayanand Kamath (Skanray Healthcare Global Private Limited), among others.